Zahra Noorani Mejareh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zahra Noorani Mejareh has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Bahare Abdollahi
Student Research Committee, School of Medical, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Samira Raoofi
Student Research Committee, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Zahra Hoseinipalangi
Student Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran
2 shared publicationsAfsaneh Dehnad
School of Health Management and Information Sciences, Tehran, Iran
1 shared publicationAhmad Ghashghaee
Social Determinants of Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication- Ahmad Ghashghaee
Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication
Latest Publications
- Open Access
- 9 February 2022
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 8, 100326
The global Prevalence of Depression among Health Workers during the COVID-19 pandemic: a Systematic review and Meta-analysis
- 9 February 2022
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 8, 100326
Open AccessThe global Prevalence of Depression among Health Workers during the COVID-19 pandemic: a Systematic review and Meta-analysis
- 22 July 2021
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (4) , 365-373
Hemodialysis and peritoneal dialysis—health-related quality of life: systematic review plus meta-analysis
Background Patients with end-stage renal disease undergoing haemodialysis experience a variety of stressors leading to decreased level of quality of life (QoL). Thus, in this study, we aimed to review the current literature and identify factors affecting the health-related QoL (HRQoL) in these patients. Methods A total of 147 studies were extracted from databases of Web of Science, PubMed, Scopus, Google Scholar, and Embase published between January 2000 and December 2020. Data were analysed using R software and results were reported with reference to Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results A total of 623 728 patients undergoing dialysis participated in 147 studies in which QoL was assessed by means of two valid questionnaires, including Short-Form 36 (SF-36) and Kidney Disease Quality of Life (KDQOL)-short form V.1.3. Total HRQoL score for patients undergoing dialysis measured by KDQOL was 64.25 (95% CI 55.67 to 72.82). Based on SF-36, the mean score of mental health items was higher than the mean score of physical health condition. Furthermore, meta-regression based on the geographical place of residence revealed that the highest QoL in patients was observed in Japan, 66.96 (95% CI 63.65 to 70.28) and Brazil, 58.03 (95% CI 53.45 to 62.6). Conclusion Studies conducted on HRQoL among patients undergoing dialysis recommend useful strategies to clinicians, letting them assess patients’ QoL in terms of a wide range of physical, mental and environmental aspects.
- 22 July 2021
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (4) , 365-373
Hemodialysis and peritoneal dialysis—health-related quality of life: systematic review plus meta-analysis
Background Patients with end-stage renal disease undergoing haemodialysis experience a variety of stressors leading to decreased level of quality of life (QoL). Thus, in this study, we aimed to review the current literature and identify factors affecting the health-related QoL (HRQoL) in these patients. Methods A total of 147 studies were extracted from databases of Web of Science, PubMed, Scopus, Google Scholar, and Embase published between January 2000 and December 2020. Data were analysed using R software and results were reported with reference to Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results A total of 623 728 patients undergoing dialysis participated in 147 studies in which QoL was assessed by means of two valid questionnaires, including Short-Form 36 (SF-36) and Kidney Disease Quality of Life (KDQOL)-short form V.1.3. Total HRQoL score for patients undergoing dialysis measured by KDQOL was 64.25 (95% CI 55.67 to 72.82). Based on SF-36, the mean score of mental health items was higher than the mean score of physical health condition. Furthermore, meta-regression based on the geographical place of residence revealed that the highest QoL in patients was observed in Japan, 66.96 (95% CI 63.65 to 70.28) and Brazil, 58.03 (95% CI 53.45 to 62.6). Conclusion Studies conducted on HRQoL among patients undergoing dialysis recommend useful strategies to clinicians, letting them assess patients’ QoL in terms of a wide range of physical, mental and environmental aspects.
- Open Access
- 2 July 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-21
Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death ( , ). This association was increased after adjustment of age interactions ( , ) and was removed after adjustment of ICU admission interactions ( , ). Hydroxychloroquine showed a protecting effect on death ( , ); however, this association was removed after adjustment of age interactions ( , ). Among the antivirals, oseltamivir showed a protecting effect on death (
- 2 July 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-21
Open AccessEffects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death ( , ). This association was increased after adjustment of age interactions ( , ) and was removed after adjustment of ICU admission interactions ( , ). Hydroxychloroquine showed a protecting effect on death ( , ); however, this association was removed after adjustment of age interactions ( , ). Among the antivirals, oseltamivir showed a protecting effect on death (